Press Releases

XORTX Welcomes New Member to the Board of Directors and Appoints Chair

XORTX to Present at H. C. Wainwright Global Investment Conference 2022

XORTX Opens an IND for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease

XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical Trial

XORTX Receives Small and Medium Enterprise Status for the European Union

XORTX Receives No Objection Letter from Health Canada

XORTX Announces Grant of US Patent

XORTX Files IND with US FDA

XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection

XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study